MDA 19

MDA 19 Basic information
Product Name:MDA 19
Synonyms:(Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide;N'-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide;MDA 19 (Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide;MDA 19;N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide;Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide;N-[(Z)-(1-Hexyl-2-oxo-indolin-3-ylidene)aMino]benzaMide;MDA19; MDA-19
CAS:1048973-47-2
MF:C21H23N3O2
MW:349.43
EINECS:200-258-5
Product Categories:
Mol File:1048973-47-2.mol
MDA 19 Structure
MDA 19 Chemical Properties
density 1.16±0.1 g/cm3 (20 ºC 760 Torr)
storage temp. Store at -20°C
solubility DMF: 20 mg/ml; DMSO: 10 mg/ml; Ethanol: 3 mg/ml; Methanol: 1 mg/ml
form A crystalline solid
pka10.45±0.20(Predicted)
Safety Information
MSDS Information
MDA 19 Usage And Synthesis
UsesMDA 19 is a selective agonist of the human peripheral cannabinoid (CB2) receptor. A cell-based functional assay showed MDA is an inverse agonist of the CB2 receptor in rat. Acts as an inverse agonist at the rat CB2 receptor. Reported Ki values are 16.3 and 1130 nM for human CB2 and CB1 receptor respectively. MDA19 was effective in attenuating tactile allodynia in neuropathic rats. MDA19 thus has potential for alleviating neuropathic pain without producing adverse effects in the central nervous system.Synthetic Cannabinoids
MDA 19 Preparation Products And Raw materials
Tag:MDA 19(1048973-47-2) Related Product Information
2-Nitro-4-methylsulfonylbenzoic acid 2,6-Dihydroxybenzoic acid 4-Methylsulphonylbenzoic acid 3,5-Dihydroxybenzoic acid